Conflicts of Interest Not Listed in Practice Parameters
Valerie Arnold, M.D.: TBD
Joseph Beitchman, M.D.: no conflicts of interest to disclose
Scott Benson, M.D.: no conflicts of interest to disclose
Allan Chrisman, M.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for Shire Pharmaceuticals Group plc, McNeil Pediatrics, Novartis Pharmaceuticals Corporation, Eli Lilly and Company, Pfizer Inc.
Tiffany Farchione, M.D.: no conflicts of interest to disclose
John Hamilton, M.D.: senior physician and shareholder in The Permanente Medical Group
Helene Keable, M.D.: no conflicts of interest to disclose
Joan Kinlan, M.D.: no conflicts of interest to disclose
Jon McClellan, M.D.: has or has received research funding Pfizer Inc.
David Rue, M.D.: no conflicts of interest to disclose
Ulrich Schoettle, M.D.: no conflicts of interest to disclose
Jon Shaw, M.D.: TBD
Matthew Siegel, M.D.: no conflicts of interest to disclose
Saundra Stock, M.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for Abbott Laboratories and Janssen, L.P.
ADHD
Russell Barkley, Ph.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for Eli Lilly and Company, Shire Pharmaceuticals Group plc, and McNeil Pediatrics. Dr. Barkley also has or has had books/intellectual property with Guilford Publications.
Joe Biederman, M.D.: receives or has received research support, served on a speaker’s bureau, or has been on the advisory board: Shire Pharmaceuticals Group plc, Eli Lilly and Company, Pfizer, Inc., McNeil, Abbott, Bristol-Myers-Squibb, New River Pharmaceuticals, Cephalon, Janssen, L.P., Novartis Pharmaceuticals, UCB Pharma, Astra-Zeneca, Forest Laboratories, Glaxo-SmithKline and Neurosearch. He has also received private foundation research support from: Stanley Medical Institute, Inc, Lilly Foundation, Prechter Foundation and from NIMH, NICHD, and NIDA.
Caryn Carlson, Ph.D.: no conflicts of interest to disclose
Mina Dulcan, M.D.: serves or has served in a governance position for Eli Lilly and Company (Strattera Global Advisory Board) and APIRE. Dr. Dulcan also serves or has served as a consultant for Comprehensive NueroScience, Inc. She also is an author/editor and member of the Editorial Advisory Board for American Psychiatric Publishing, Inc.
Gregory Fabiano, M.A.: no conflicts of interest to disclose
Joan Gerring, M.D.: no conflicts of interest to disclose
Larry Greenhill, M.D.:
-
Eli Lilly: Consultant; Member of the Data Mining Board; Author on papers with employees of Eli Lilly; Support for travel to IACAPAP meeting in Australia; potential support for travel and planning meetings for ESCAP meetings in Florence, Italy.
-
Novartis: Honorarium to attend two scientific advisory boards; Signed contract to accept support for research at my institution, but no patients were recruited because study closed before contract negotiations were complete.
-
New River Pharmaceuticals: Signed contract to accept support for research at my institution, but no patients were recruited because study closed before contract negotiations were complete.
-
McNeil Pharmaceuticals: Signed contract to accept support for research at my institution, but no patients were recruited because study closed before contract negotiations were complete.
-
Forest Pharmaceuticals: Signed contract to accept support for research at my institution, but no patients were recruited because study closed before contract negotiations were complete.
-
Otsuka Pharmaceuticals: Received support for a research contracts in the form of payment to generate similar appearing active drug and placebo.
Pfizer: Received honorarium to lecture at a Pfizer investigator meeting and for work as chairman of the Ziprasidone Pediatric Data Safety and Monitoring Board. -
Janzen-Cilag: Received honorarium to give a 2 hour seminar in Melbourne Australia to practitioners.
-
Johnson and Johnson: Received honorarium to participate in a phone call for a Scientific Advisory Panel.
Paul Hammerness, M.D.: serves or has served on speaker’s bureau for Shire Pharmaceuticals Group plc and contributes to Medscape.
Lily Hechtman, M.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for Eli Lilly and Company, Janssen, L.P., Purdue, and Shire Pharmaceuticals Group plc. Dr. Hechtman also serves or has served in a governance position with CADDRA (Canadian ADHD Resource Alliance).
Catherine Jaselskis, M.D.: no conflicts of interest to disclose
Guy Palmes, M.D.: serves on speakers bureau for McNeil Pediatrics
William Pelham, Ph.D.: TBD
Cynthia W. Santos, M.D.: serves in governance position at ABPN
Thomas Spencer, M.D.: TBD
James Swanson, Ph.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for McNeil, UCB, Eli Lilly and Company, Cephalon, Janssen, L.P., and Novartis Pharmaceuticals.
Daniel Waschbusch, Ph.D.: receives or has received research support from Eli Lilly and Company
Timothy Wilens, M.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for Abbott Laboratories, Cephalon, Ortho-McNeil, Eli Lilly and Company, National Institute on Drug Abuse, Neurosearch, Shire Laboratories, Inc., Novartis Pharmaceuticals, Janssen, L.P., National Institute on Mental Health, and Pfizer, Inc.
Depressive Disorders
Jeffrey Bridge, Ph.D.: TBD
Amy Cheung, M.D.: TBD
Greg Clarke, Ph.D.: TBD
Graham Emslie M.D.: receives or has received research support from Eli Lilly, Organon, and Forest Laboraties, serves or has served as a consultant for Eli Lilly, GlaxoSmithKline, Wyeth-Ayerst, and Biobehavioral Diagnostics Inc., and has served or is serving on the speaker's bureau for McNeil Pharmaceuticals.
Philip Hazell, M.D.: serves or has served on Advisory Boards for Lilly and Novartis, serves or has served on the speaker's bureau's for Lilly and Janssen, and receives or has received research support from Lilly. Dr. Hazell also has or has had intellectual property with the British Medical Journal Publishing Group.
Michael Houston, M.D.: President of the Washington Psychiatric Association and on the board of Directors for the Federation for Families for Children's Mental Health.
Stan Kutcher, M.D.: serves or has served on the board of Canadian Psychiatric Research Foundation, the Canadian Society for International Health, and Interhealth Canada.
Laura Mufson, Ph.D.: no conflicts of interest to disclose
Syed Naqvi, M.D.: received the young investigator award from NARSAD, received a research grant to study the role of PUFA in Adolescent Depression, acted as a consultant and/or served on a speaker's bureau for Jansen Pharmaceuticals, The Medical Education Speakers Network, and an independent medical speaker's bureau for CME professionals.
Kelly Posner, Ph.D.: TBD
Joseph Rey, M.D.: no conflicts of interest to disclose
Karen Wagner, M.D.: TBD
Elizabeth Weller, M.D.:TBD
Family Assessment
Eugene Beresin, M.D.: no conflicts of interest to disclose
Lee Combrinck-Graham, M.D.: no conflicts of interest to disclose
Geri Fox, M.D.: no conflicts of interest to disclose
Rao Gogineni, M.D.: no conflicts of interest to disclose
Gordon Hodas, M.D.: no conflicts of interest to disclose
David Kaye, M.D.: receives or has received research funding from Pfizer, Inc.
David Keith, M.D.: TBD
Douglas Kramer, M.D.: TBD
Charles Malone, M.D.: no conflicts of interest to disclose
Beatrice Wood, Ph.D.: TBD
Post Traumatic Stress Disorder
Lisa Amaya-Jackson: receives or has received research support from the Substance Abuse and Mental Health Services Administration (SAMHSA).
Jeanne Bereiter: has no financial relationships to disclose.
Nancy Black: has no financial relationships to disclose.
Efrain Bleiberg: is an officer of the Society of Professors of Child and Adolescent Psychiatry. He has no financial relationships to disclose.
Michael De Bellis: receives or has received research support from the National Institutes of Health (NIH).
Gail Edelsohn: has no financial relationship to disclose.
Helen Egger:TBD.
Paramjit Joshi: serves on the American Board of Psychiatry and Neurology. She has no financial relationships to disclose.
Anthony Mannarino: receives or has received research support from the National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
He has a book published with Guilford Press.
He is a Section President of the American Psychological Association.
Yiu Kee Warren Ng: has no financial relationship to disclose.
Frank Putnam: serves as a Trustee of the Ohio Children’s’ Trust Fund. He has no financial relationships to disclose.
Robert Pynoos: has no financial relationships to disclose.
Ken Rogers: has no financial relationships to disclose.
Michael Scheeringa: has no financial relationships to disclose.
Susan Scherer: has no financial relationships to disclose.
Psychotropic Medications
Larry Greenhill, M.D.: receives or has received research support from Otsuka, Johnson and Johnson, and the National Institute of Mental Health (NIMH).
Christopher Kratochvil, M.D.: receives or has received research support, acted as a consultant for: Eli Lilly and Company; Shire Pharmaceutical Inc.; Abbott; and Somerset Pharmaceutical Inc. Is/was Member of the Data and Safety Monitoring Board (DSMB) for Pfizer.
Aradhana Bela Sood:M.D.: Member of the VA state board of social services, AACAP assembly, AACAP council. Chair of VCU division of child psychiatry.
Mark Riddle, M.D.: no conflicts of interest to disclose
Timothy Wilens, M.D.: receives or has received research support, acted as a consultant and/or served on a speaker's bureau for: Abbott Laboratories; Cephalon, Inc.; Ortho-McNeil ; Eli Lilly and Company; National Institute on Drug Abuse; Neurosearch; Shire Laboratories, Inc.; Novartis Pharmaceutical Corporation, Janssen, L.P.; National Institute on Mental Health; and Pfizer, Inc.
Charles H. Zeanah, M.D.: has or has had books/intellectual property with Guilford Press.
Susan Daily, M.D.: serves or has served on speaker’s bureau for Forrest and BMS.
Daniel S. Pine. M.D.: Research scientist at the National Institute of Health (NIH). Deputy Editor of the American Journal of Psychiatry. Gave lectures for various CME programs.
